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Abstract. Background: The functions of superoxide
dismutase-3 (SOD3), which acts on the cell surface and
protects cells from oxidative stress, remain uncertain in
progression of prostate cancer. Materials and Methods: To
verify SOD3 expression in human prostate tissue,
immunohistochemistry was performed using tissue
microarray. To investigate the effects of SOD3 on
proliferation, migration, and invasion, SOD3 was
overexpressed and recombinant SOD3 was employed in PC-
3 prostate cancer cells. H2O2 level, reduced glutathione
(GSH)/ oxidized glutathione (GSSG) ratio, catalase activity,
and 8-oxo-2’-deoxyguanosine (8-OHdG) were estimated in
SOD3-overexpressing PC-3 cells. Results: Immunohisto-
chemistry revealed reduced expression of SOD3 in prostate
cancer tissue. SOD3 overexpression in PC-3 cells inhibited
cell proliferation, migration, and invasion. Recombinant
SOD3 had the same effect. H2O2 accumulation was
increased by SOD3 overexpression, GSH/GSSG ratio
decreased, and catalase activity decreased. DNA damage in
SOD3-overexpressing cells was confirmed by 8-OHdG
elevation. Conclusion: Since SOD3 acts as a tumor
suppressor, SOD3 overexpression and recombinant SOD3
might lead to treatment for prostate cancer.
Prostate cancer and castration-resistant prostate cancer
(CRPC) can progress into a more advanced level via
generation of oxidative stress, which can induce the
formation of reactive oxygen species (ROS), as well as
activation of androgen receptor (1). Usually, antioxidant
enzymes function to preserve cell damage by ROS. However,
cell defense systems can be destroyed if ROS generation is
tremendously increased (2). It has been reported that the
activity and expression level of several antioxidant enzymes
are low in prostate cancer tissue (3, 4). Thus, it is important
to explore the correlation between antioxidant enzymes
directly related to ROS and prostate cancer.
Superoxide dismutases (SODs) have been shown to be the
first line of antioxidants that protect cells against detrimental
oxidative stress by catalyzing the two superoxide radicals
(O2•–) to hydrogen peroxide (H2O2) and oxygen (O2) (5, 6).
There are three isoforms in human SODs, SOD1 (copper-zinc
SOD; CuZnSOD), SOD2 (manganese SOD; MnSOD), and
SOD3 (extracellular SOD; EcSOD) (7). SOD2 overexpression
reduced the growth, proliferation, and invasion of human lung
cancer (8). It also reduced cell growth of SOD2-
overexpressing prostate cancer PC-3 cells (9). The high level
of H2O2 produced by SOD2 overexpression might contribute
to the anti-proliferative function. In highly proliferative
cancer cells, ROS are ironically accumulated by up-regulation
of antioxidant enzymes in genetically manipulated cells (10).
Although a high level of ROS in cancer cells can induce
tumorigenesis, ROS also increase the susceptibility of cancer
cells to death (11). 
SOD3 is known as the only antioxidant enzyme which
acts on the extracellular matrix (12) in only a few cell types
(13). SOD3 can be present both within cells and in
conditioned media (7, 14). It was reported that SOD3
overexpression is correlated with down-regulation of matrix
metalloproteinases (MMPs) activity and cell invasion in
prostate cancer cells (14). 
However, the influence of SOD3 on cell proliferation or
migration of prostate cancer cells has not yet been well
elucidated. In the present study, we focused on the alteration
of cell proliferation, migration, and invasion in terms of the
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cellular redox state, which has significant effects on the
supervision for cell survival by SOD3. 
Materials and Methods
Immunohistochemistry. Two types of prostate cancer tissue
microarrays (TMAs, 4012209 and A302IV) were purchased from
Provitro (Berlin, Germany) and Isu Abxis Co. Ltd. (South Korea),
respectively. Immunohistochemical (IHC) staining was performed
through the Dako ChemMate ENVISION Kit/HRP (DAB)-universal
kit (K5007) according to the manufacturer’s protocol (Dako,
Carpinteria, CA, USA) and the method described by Shin et al.
(15). Tissue specimens were stained with rabbit polyclonal
antibodies against SOD3 (Santacruz Biotechnology, Inc. Dallas, TX,
USA). 
Cell culture. Human prostate carcinoma cell line PC-3 (ATCC,
Manassas, VA, USA) were cultured in RPMI-1640 (Sigma-Aldrich,
St. Louis, MO, USA) supplemented with 1% penicillin/streptomycin
(Invitrogen, Carlsbad, CA, USA) and 10% fetal bovine serum
(Sigma-Aldrich). The medium was changed every 2-3 days, and
cells were routinely grown in 75-cm2 vented tissue culture flasks at
37˚C in a humidified atmosphere of 5% CO2. 
DNA transfection. PC-3 cells were transiently and stably transfected
with 0.25, 0.5, and 1 μg of pCMV6-SOD3 plasmid or pCMV6-
Entry plasmid as a vector control (OriGene Technologies, Rockville,
MD, USA) by Lipofectamine Reagent (Invitrogen) according to the
manufacturer’s instructions. To construct the stable transfection,
after transfection of PC-3 cells with 1 μg of pCMV6-SOD3 or
pCMV6-Entry, the clones were selected with 200 μg/ml of G418
(Sigma-Aldrich) and isolated by cloning rings for further selection
(PC-3/SOD3 and PC-3/Entry, respectively). The selected clones
were confirmed by western blot analysis for the level of SOD3
expression and the media in which transfected cells were cultured
were also collected to evaluate SOD3. 
Preparation of conditioned media. PC-3/SOD3 or PC-3/Entry cells
were maintained for 3-5 days after their subculture. Their
conditioned media were concentrated by Amicon Ultra-15
Centrifugal Filter Devices (EMD Millipore, Merck KGaA,
Darmstadt, Germany). The treated protein amount in conditioned
media from PC-3 cells was 500 μg or 1000 μg by the same
measurement for protein in western blot analyses. 
SOD activity assay. Cell lysates were extracted by adding 200 μl of
Mammalian Protein Extract Reagent (M-PER; PIERCE, Rockford,
IL, USA) to a 60 mm culture dish with cells and by sonication. This
assay was applied to 100 μl of each cell lysates by sandwich
enzyme-linked immunosorbent assay (ELISA) Assay Kit according
to the manufacturer’s protocol (Northwest Life Science Specialties,
LLC, Vancouver, Canada). The 96-well plate provided in the kit was
pre-coated with a monoclonal antibody specific to human SOD3 and
the absorbance was read at 450 nm. 
Reverse-transcription polymerase chain reaction. Total cellular
RNA was extracted by using RNeasy Mini Kit (Qiagen, Valencia,
CA, USA) according to the protocol described by the manufacturer.
RT-PCR was carried out using the iScript cDNA Synthesis Kit (Bio-
Rad, Hercules, CA, USA) and Ex Taq DNA polymerase (TaKaRa,
Shiga, Japan). The primers were SOD1 sense: 5’-TGGAGACTTG
GGCAATGTGACTGCT-3’ and anti-sense: 5’-GGGCCTCAGA
CTACATCCAAGGGAA-3’; SOD2 sense: 5’-CCCAGATAGCTC
TTCAGCCTGCACT-3’ and anti-sense: 5’-TAAGCGTGCTCCC
ACACATCAATCC-3’; SOD3 sense: 5’-TCGTCCTCTTCCGGCA
GCTT-3’ and anti-sense: 5’-GCTTCTTGCGCTCTGAGTGCT-3’;
MMP2 sense: 5’-TACCACGGCCAACTACGACA-3’ and anti-sense:
5’-ATGATCTAAGCCCAGCGCGT-3’; MMP9 sense: 5’-TACC
ACGGCCAACTACGACA-3’ and anti-sense: 5’-AAAGTTCGA
GGTGGTAGCGC-3’; glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) sense: 5’-CCACCCATGGCAAATTC CATGGCA-3’ and
anti-sense: 5’-TCTAGACGGCAGGTCAGG TCCACC-3’. The
annealing temperature of RT-PCR and PCR cycle number were
62˚C and 33 cycles for SOD3, MMP2, and MMP9, 65˚C and 25
cycles for SOD1 and SOD2, and 65˚C and 20 cycles for GAPDH as
a control.
Western blot analysis. Total proteins were extracted from cells by
adding 200 μl of M-PER (PIERCE) to 100 mm culture dish of PC-
3/SOD3 and PC-3/Entry cells. Proteins were quantified according
to the method of Bradford and more than 50 μg of proteins loaded
on a 12.5% Ready Gel J (Bio-Rad). Western blot analysis was
carried out as described by Shin et al. and antibodies to SOD1,
SOD2, and SOD3 were purchased from Santacruz Biotechnology,
Inc. (diluted 1:200) (15).
Native gel activity assay. Concentrated conditioned media blended
with an equal volume of a native sample buffer (Bio-Rad) were
loaded onto a 4-20% polyacrylamide gel and electrophoresis was
performed in nondenaturing running buffer (pH 8.3) at 50 V for 5 h.
The activity of SOD on the gel was visualized by the staining
procedure described by Beauchamp and Fridovich (16). Another gel
onto which was loaded with the same sample was incubated with
50 mM phosphate buffer (pH 7.8) containing 5 mM H2O2 (Nacalai
Tesque, Kyoto, Japan) at room temperature for 15 min prior to
soaking in riboflavin- nitroblue tetrazolium (NBT) solution. 
Cell proliferation assay. One day after PC-3 cells were plated at a
density of 1×105 cells onto 6-well plates with RPMI-1640 (Sigma-
Aldrich) containing 10% fetal bovine serum (Sigma-Aldrich)
without penicillin/streptomycin, the cells were transiently
transfected with 1 μg of pCMV6-Entry or pCMV6-SOD3. Then
cells were counted using a hemocytometer at 24, 48, and 72 h after
transfection in triplicate. PC-3 cells were also treated with
conditioned media of PC-3/Entry and PC-3/SOD3 cells or the
purified recombinant human SOD3 protein (OriGene Technologies,
Inc) after cells were plated at a density of 1×105 cells onto 6-well
plates. Then cells were cultured for the indicated periods (48 h or 72
h) and counted using a hemocytometer. The data represent the
means±SD in triplicate. 
Wound-healing assay. Cells were plated at a density of 2×105 cells
onto 60 mm culture dish. Twenty-four hours later, cells were
transiently transfected with pCMV6-SOD3 or pCMV6-Entry at a
concentration of 0.25, 0.5, and 1 μg. Five hours after transfection,
the media were changed to complete media and with a pipette tip, a
wound space in the confluent monolayer was made. Cells migrating
from the leading edge were photographed at 24, 48, and 72 h after
transfection. PC-3 cells were also plated at a density of 2×105 cells
onto 6-well plates for treatment with conditioned media or 12-well
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plates for treatment with recombinant SOD3 protein. The data
represent the means±SD of three replicates. 
Cell invasion assay. Cell invasion assay was performed using a kit
(Chemicon, Temecula, CA, USA) according to the manufacturer’s
instructions. The cells were suspended in 300 μl of serum-free
medium, and were transiently transfected with 1 μg of pCMV6-
SOD3 or pCMV6-Entry vector overnight then placed into inserts
and were incubated in a tissue culture incubator for 24, 48, and 72
h. The inserts were gently removed using a cotton-tipped swab.
After staining inserts, they were dipped into a beaker of water
several times to rinse and air-dried. These arrays were performed
three times, and similar results were obtained.
MMP zymography. Enzymatic activities of MMP2 and MMP9 were
determined by Gelatin Zymography Kit (Primary Cell Co., Ltd.,
Japan). Concentrated conditioned media blended with equivalent
volume of 2× Sample Preparation Buffer were loaded onto a 10%
polyacrylamide gel and electrophoresis was performed in
Electrophoresis Running Buffer pH 8.3 in 100 V for 2 h. The gel was
rinsed with Washing Buffer and incubated at room temperature for 1 h
and then incubated with 50 ml of Reaction Buffer at 37˚C overnight.
The gel was stained with Staining Solution at room temperature for
30 min and was destained at room temperature for 30 min. 
ROS/Superoxide detection assay. Cells transiently transfected with 1
μg of pCMV6-Entry or pCMV6-SOD3 were loaded with
ROS/Superoxide Detection Mix of Total ROS/Superoxide Detection
Kit (Enzo Life Sciences, Inc.) at 37˚C incubator for 1 h. The Mix
was removed and washed with 1× Wash Buffer. They were observed
under a fluorescence/confocal microscope using standard
excitation/emission filter sets. 
8-OHdG estimation. DNA was extracted from PC-3/Entry and PC-
3/SOD3 cells using EX-R&D Kit (Medical & Biological
Laboratories Co., Ltd., Japan) according to the manufacturer’s
instructions. After DNA extraction, 8-OHdG estimation was
performed by HT 8-oxo-dG ELISA Kit II (TREVIGEN,
Gaithersburg, MD, USA) according to the manufacturer’s
instructions. The absorbance was read at 450 nm. 
GSH/GSSG ratio assay. GSH/GSSG Quantification Kit (DOJINDO
Molecular Technologies, Inc., Rockville, MD, USA) was used to
measure reduced and oxidized glutathione in pCMV6-Entry and PC-
3/SOD3 cells. The homogenized pellets which were treated with 5%
metaphosphoric acid in PBS were centrifuged. The supernatants were
then added to the 96-well plate. All steps were performed as per the
manufacturer’s instructions. After adding the substrate solution,
coenzyme solution and enzyme solution, the reaction change was
monitored every 2 min for 10 min at an absorbance at 415 nm. 
Hydrogen peroxide assay. The amount of 100 μg and 1000 μg of
proteins acquired from the conditioned media of PC-3/SOD3 or PC-
3/Entry cells were assessed. BIOXYTECH H2O2 560™ Quantitative
Hydrogen Peroxide Assay Kit (OXIS International, Inc., Portland,
OR, USA) was used for production of H2O2. Absorbance was read
at 560 nm. 
Catalase activity assay. Catalase Assay Kit (Abcam, Cambridge,
MA, USA) was used to measure catalase activity. Homogenized PC-
3/SOD3 or PC-3/Entry cells (106) in 200 μl of cold Assay Buffer
were centrifuged at 10,000× g for 15 min at 4˚C and the supernatant
collected for assay. We followed the manufacturer’s instructions for
this assay.
Statistical analysis. All experiments were carried out in triplicates
and mean values±SD are shown. Statistical significance was
determined by utilizing Prism 5.0 (GraphPad Software, San Diego,
CA, USA). The χ2 test was used to assess the significance between
different proportions. Analysis of continuous variables between
different groups was assessed by one-way ANOVA or two-way
ANOVA. Differences between two groups were analyzed by
Student’s t-test. Kruskal–Wallis test was used to determine the
statistical significance of differences in IHC staining of tissue
microarrays. 
Results
Evaluation of SOD3 expression in prostate cancer and
normal prostate. In order to identify the genes differentially
expressed between normal prostate and prostate cancer
tissue, we previously compared the expression profiles of
three normal prostate biopsy samples and each of three
prostate cancer samples using cDNA microarray analysis
(Whole Human Genome Microarry 4× 44K (Agilent
Technologies; GEO accession number: GSE 30994) (17).
This analysis identified SOD3 gene as being decreased to
21% in prostate cancer tissues compared with normal
prostate tissues. The expression levels of SOD1 and SOD2
in PCa tissues were not different from those in normal
prostate tissues (data not shown). 
To investigate expression level of SOD3 in normal
prostate and PCa tissues, we first performed immuno-
histochemistry (IHC) via tissue microarrays (TMAs). As
shown in (Figure 1 A), we classified the intensity of the
staining of SOD3 as four levels, 0, 1+, 2+, and 3+. IHC
revealed that 95% (40/42) of normal prostate tissues showed
positive expression for SOD3, whereas only 41% (38/92) of
prostate cancer tissues showed positive expression for SOD3.
Interestingly, among these positive cases, the ratio of strong
expression of over 2+ was 67% (28/42) in normal prostate
tissues and 15% (14/92) of prostate cancer tissues (p<0.05)
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Table I. Immunohistochemistry of superoxide dismutase 3 on prostate
tissue microarray.
Clinicopathological Intensity of SOD3
feature
0 1+ 2+ 3+ Total p-Value
Normal 2 12 4 24 42
Gleason score 5, 6 14 8 4 0 26 <0.05
Gleason score 7 27 9 7 1 44 <0.05
Gleason score 8, 9, 10 13 7 1 1 22 <0.05
(Table I). However, this result was not correlated with
Gleason score, age, tumor invasion, or T stage.
Overexpression of SOD3 in PC-3 cells. First, we examined
whether SODs are expressed in androgen-independent
prostate cancer cell lines by RT-PCR and western blot
analyses (Figure 2A). SOD1 and SOD2 were strongly
expressed in PC-3 cells. However, SOD3 was not expressed
in PC-3 cells. To explore the effect of SOD3 in PC-3 cells,
we transfected PC-3 cells with pCMV6-SOD3 transiently and
the activity for SOD3 in the cell lysate was examined by
ELISA (Figure 2B). The activity of PC-3 cells transfected
with pCMV6-SOD3 was elevated in a dose-dependent
manner compared to those cells frustrated with pCMV6-
Entry. Moreover, we successfully generated stable SOD3-
overexpressing PC-3 cells (PC-3/SOD3) and confirmed the
expression of SOD3 mRNA and protein (Figure 2C). The
activity of SOD3 in the conditioned media was also identified
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Figure 1. Immunohistochemistry of superoxide dismutase 3 (SOD3) in prostate tissue. A: Immunohistochemical expression patterns of SOD3 on the
tissue microarray of non-neoplastic speimens and prostate cancer (PCa). The upper panels show normal specimens (i-v) and the lower panels
indicate prostate cancers (vi-x). i: normal (intensity 3+) from vi, ii: normal (intensity 3+) from vii, iii: normal (intensity 3+) from viii, iv: normal
(intensity 3+) from ix, v: normal (intensity 2+) from x, vi: cancer with Gleason score 7 (intensity 0), vii: cancer with Gleason score 7 (intensity 2+),
viii: cancer with Gleason score 7 (intensity 0), ix: cancer with Gleason score 8 (intensity 0), x: cancer with Gleason score 9 (intensity 1+). B:
Quantitative analysis of sections as shown in A. All panels shown at ×40 magnification, the areas of the field indicated are shown enlarged as seen
at ×100 magnification.
by gel enzymatic assay (Figure 2D). Here, this activity of
SOD3 can be inhibited or inactivated by various agents such
as H2O2, azide, cyanide, and dietheldithio-carbamate (5). We
confirmed that SOD3 was reduced by addition of H2O2
(Figure 2D). Thus, we verified the existence of SOD3 in PC-
3 cells in the cell lysates as well as in the media. 
Overexpression of SOD3 suppresses cell proliferation. It has
been reported that overexpression of SOD2 has an inhibitory
effect on the growth of PC-3 cells as a tumor-suppressor
gene (9). We investigated whether SOD3 could suppress cell
proliferation as well as SOD2. The proliferation of PC-3
cells transiently transfected with pCMV6-SOD3 remarkably
decreased in a time-dependent manner compared to those
with pCMV6-Entry. To see the effect of SOD3 at the
extracellular surface, we used conditioned media from PC-
3/SOD3 or PC-3/Entry cells, and treated PC-3 cells with
them. The proliferation of PC-3 cells was inhibited by 500
or 1000 μg of conditioned media of PC-3/SOD3 cells more
than that of PC-3/Entry cells (Figure 3B). Moreover, we
utilized purified recombinant human SOD3 protein to
confirm the effect of SOD3 on cell growth inhibition (Figure
3C). Treatment of PC-3 cells with recombinant SOD3
protein caused the inhibition of cell proliferation in a dose-
dependent manner, suggesting that SOD3 functions as a
tumor suppressor in PC-3 cells. 
Overexpression of SOD3 inhibits cell migration and invasion
and inactivates MMP2 and MMP9. We further investigated
if SOD3 affects the cell migration and invasion of PC-3 cells.
Firstly, we performed the wound-healing assay to explore
cell migration using cells transiently transfected with
pCMV6-SOD3. We found a dose-dependent difference in
migration between PC-3 cells transfected with pCMV6-Entry
and pCMV6-SOD3 (Figure 4A). Next, to confirm the effect
of SOD3 on cell invasion, the cells transiently transfected
with pCMV6-SOD3 or pCMV6-Entry were applied to an
invasion assay. The number of invaded cells was significantly
reduced by SOD3 by 79.7%, 92.8%, and 97.1% at 24, 48,
and 72 h, respectively (Figure 4B). 
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Figure 2. Superoxide dismutases (SODs) and stable transfection of SOD3 in PC-3 cells. A: mRNA and protein expression of endogenous SODs in
PC-3 cells. B: After PC-3 cells were transiently transfected with pCMV6-SOD3 and pCMV6-Entry, SOD3 activity of the cell lysates was measured
by ELISA. **p<0.05 and ***p<0.001. C: Expression of SOD3 mRNA and protein of PC-3/Entry and PC-3/SOD3. D: SOD3 activity was assayed in
conditioned media including 300 μg of protein by native gel electrophoresis. After electrophoresis, the gel was stained for SOD3 activity and
confirmed with 5 mM of H2O2, one of agents for inhibition of SOD3 activity.
Furthermore, we investigated the effect of the conditioned
media derived from PC-3/SOD3 cells (Figure 4C) and
recombinant human SOD3 protein on migration of PC-3
cells (Figure 4D). Conditioned media derived from PC-
3/SOD3 and recombinant SOD3 protein also inhibited
migration of PC-3 cells in a dose-dependent manner. 
Since cancer invasion is closely connected with MMPs
regarding extracellular matrix renovation (18), we
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Figure 3. Effect of superoxide dismutase 3 on cell proliferation of PC-3 cells. A: After transfection of PC-3 cells with pCMV6-Entry or pCMV6-SOD3,
the cells were photographed and counted in triplicate at 24, 48, and 72 h. B: After 500 μg or 1000 μg of conditioned media derived from PC-
3/SOD3 or PC-3/Entry cells was added to PC-3 cell cultures, cells were photographed and counted at 24, 48, and 72 h. C: After recombinant human
SOD3 protein was added to PC-3 cells, the cells were photographed at 24, 48, and 72 h and counted at 72 h. **p<0.05 and ***p<0.001.
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Figure 4. Effect of superoxide dismutase 3 on cell migration and invasion in PC-3 cells. A: Migrated cells were photographed at 24, 48, and 72 h
after transfection. B: Cells transiently transfected with 1 μg of pCMV6-SOD3 or pCMV6-Entry were applied to an invasion assay and the cells that
invaded the membrane were observed for 24, 48, and 72 h. ***p<0.001. C: Migration assay of PC-3 cells was carried out after treatment of
conditioned media including 500 μg or 1000 μg protein from PC-3/SOD3 or PC-3/Entry cells. D: Migration assay of PC-3 cells was carried out with
treatment of purified recombinant human SOD3 protein. E: The mRNA level of matrix metalloproteinase (MMP) 2 and MMP9 was measured by
reverse-transcription polymerase chain reaction in PC-3 cells transfected with 1 μg of pCMV6-SOD3 or pCMV6-Entry for 48 h (left) and the activity
of MMP2 and MMP9 was assessed by zymography (right).
investigated the expression and activity of MMP2 and
MMP9 in PC-3 cells transfected with pCMV6-SOD3 or
pCMV6-Entry (Figure 4E). The expression of MMP2 and
MMP9 mRNA was down-regulated in pCMV6-SOD3 cells
compared to pCMV6-Entry cells. Zymographic analysis also
revealed that the activity of MMP2 and MMP9 was reduced
in pCMV6-SOD3 cells in accordance with the expression of
MMPs, suggesting that SOD3 impacts extracellularly and
intracellularly on cancer cell movement, such as migration
and invasion, by reducing activity of MMP2 and MMP9 in
PC-3 cells.
Overexpression of SOD3 changes cellular redox state and
lead to accumulation of H2O2. It has been reported that
oxidative stress caused by ROS is related to prostate cancer
progression and aggressiveness (19, 20). Therefore, we
wondered whether ROS production or O2•– change as a
fundamental function of SOD3 could be observed. We
investigated total ROS/superoxide in PC-3 cells transfected
with pCMV6-SOD3 and pCMV6-Entry (Figure 5A).
Although the total ROS level was not changed irrespective of
SOD3 overexpression, O2•– level was significantly reduced on
SOD3 overexpression at 48, and 72 h after transfection.
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Figure 5. Effect of superoxide dismutase 3 on reactive oxygen species and H2O2 production by PC-3 cells. A: Total ROS and O2•– detection in PC-
3 cells after transfection with pCMV6-SOD3 or pCMV6-Entry at 48, and 72 h. Green and orange fluorescence represent total ROS and O2•–,
respectively. Pyocyanin and N-acetyl-L-cysteine were used as a positive control (Pos.) and a negative control (Neg.), respectively. B: H2O2 production
with conditioned media including 100 μg or 1000 μg protein from PC-3/SOD3 and PC-3/Entry cells was detected by microplate reader. C: Catalase
(CAT) activity was assessed for the cell lysates of PC-3/SOD3 or PC-3/Entry cells. D: Reduced glutathione (GSH)/ oxidized glutathione (GSSG) ratio
in PC-3/SOD3 and PC-3/Entry cells was assessed. E: DNA damage as 8-oxo-2’-deoxyguanosine (8-OHdG) level in PC-3/SOD3 and PC-3/Entry cells
was measured. Mean±SD was used at least three independent samples per group. ***p<0.0001.
H2O2, representative of oxidative stress, is the product of
dismutation by SODs. H2O2 produced in SOD3-overexpressing
cells should be accumulated either in the intracellular
environment or in the extracellular one if the removal system
for H2O2, detoxification, is not appropriate. Thus, we measured
H2O2 production with 100 μg and 1000 μg of conditioned
media derived from PC-3/SOD3 cells (Figure 5B). We
measured extracellular H2O2 because of its fast diffusing
properties towards the outside of cells and cumulative
characteristics in the media (9, 21). H2O2 produced in PC-
3/SOD3 cells was remarkably accumulated in a dose-
dependent manner compared with that of PC-3/Entry cells. 
H2O2 should be removed by catalase in the cellular
environment (22, 23). However, catalase activity in PC-
3/SOD3 cells was low compared to that of PC-3/Entry cells
(Figure 5C). Moreover, GSH is oxidized by reacting with
H2O2 and converted to GSSG. Glutathione peroxidase is
involved in this reaction. Therefore, we compared
glutathione peroxidase activity between PC-3/Entry and PC-
3/SOD3 cells. However, glutathione peroxidase activity was
not different between these cells (data not shown). Since the
GSH/GSSG ratio is a marker of oxidative stress, and with
decreased GSH cells cannot eliminate H2O2 well (24), the
ratio in PC-3/SOD3 and PC-3/Entry cells was also examined.
The ratio of PC-3/SOD3 cells decreased to half of that of
PC-3/Entry (Figure 5D). These results suggested that H2O2
produced by overexpression of SOD3 was accumulated due
to low CAT activity and decreased GSH/GSSG ratio. 
Finally, in order to reveal the DNA damage produced by
H2O2, we examined 8-OHdG production (Figure 5E). DNA
damage in PC-3/SOD3 cells was twice as high as that of PC-
3/Entry cells, suggesting that the cells transfected with
pCMV6-SOD3 under the condition of an excessive amount
of H2O2 by manipulation of antioxidant enzyme could affect
cell proliferation, migration, and invasion via DNA damage.
Discussion
There have been lots of investigations into SODs in a variety
of human cancer cell types, including prostate, breast, and
lung cancer (4, 18). Baker et al. demonstrated that the
expressions of antioxidant enzymes such as CAT, SOD1, and
SOD2 were lower in PCa tissues compared with those of
normal tissues (3). However, SOD3 expression has not been
evaluated yet. Our previous cDNA microarray analysis
revealed differences in the SOD3 expression of biopsy
samples between normal prostate and prostate cancer (17).
We investigated whether the expression of SOD3 in prostate
cancer tissues is different from that in normal tissues. The
expression level of SOD3 was reduced in prostate cancer
tissues compared to that of normal tissue derived from the
same patients. It remains unclear why SOD3 expression is
reduced in tissue. However, SOD3 could become a
biomarker of prostate cancer pathologically, although
malignant grade did not influence expression of SOD3. 
We characterized functions of SDO3 to evaluate whether
SOD3 is a tumor-suppressor gene, as well as a biomarker of
prostate cancer. We then investigated the effect of SOD3 on
cell proliferation, migration, and invasion of prostate cancer
cells. SOD3 overexpression reduced cell proliferation of PC-
3 cells. Furthermore, conditioned media of PC-3/SOD3 cells
repressed the proliferation of PC-3 cells, suggesting that
SOD3 itself or other unknown secreted factors regulated by
overexpression of SOD3 might affect cell proliferation.
Experiments with purified recombinant human SOD3 protein
indicated the possibility that one of unknown factors is
SOD3 protein. 
We further focused on cell migration and invasion to
assess how SOD3 overexpression affects cancer cell
migration. We found that transfect ion of PC-3 cells with
SOD3 suppressed prostate cancer cell progression. In
general, it is well-known that some MMP family members,
MMP2 and MMP9, play an essential role in tumor invasion
and angiogenesis in many types of cancer, and they are more
activated and increased when cancer progresses through the
higher grades (25). ROS generation may induce migration
and invasion by activating MMP2 and MMP9 in prostate
cancer cells (19, 26-28). In contrast, excessive ROS can also
elicit cancer cell death such as apoptosis or diverse cell
damage (29, 30). Moreover, Ganguly et al. described that
MMP2 was down-regulated by exogenous H2O2 (31).
Although the total ROS level was not changed by
overexpression of SOD3 in the present study, accumulation
of H2O2 by overexpression of SOD3 attenuated MMP2 and
MMP9, in accordance with its inhibiting influence on cell
invasion. 
We confirmed that O2•– was decreased and the level of
H2O2 was increased in SOD3-overexpressing PC-3 cells
because of the action of dismutation of SOD3. It has been
demonstrated that SOD2 overexpression inhibits cell growth
caused by elevation of H2O2 in PC-3 cells and DU145 cells
(9, 32). One of the reasons that SOD3 suppressed cell growth
in PC-3 cells might by production of H2O2. We performed
H2O2 generation assay by means of the conditioned media
of PC-3/SOD3 cells due to membrane permeability of H2O2
(33). Here we observed accumulation of H2O2 in the
conditioned media of PC-3/SOD3 cells. Increased H2O2 is
usually eliminated by GSH binding and catalase (18, 34).
However, the GSH/GSSG ratio and catalase activity in PC-
3/SOD3 cells were rather lower than those of PC-3/Entry
cells, suggesting that H2O2 produced due to SOD3
overexpression is not eliminated and is therefore
accumulated. Furthermore, GSH is known to protect cells
against free radicals, and GSH deficiency might stimulate cell
death, including apoptosis, in cancer cells (35). SOD3
overexpression may also induce stimulation of cell death via
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inhibition of GSH. It remains unknown why catalase activity
and GSH/GSSG ratio were reduced by SOD3 overexpression.
We are now investigating the mechanisms involved in this.
It was reported that 8-OHdG was highly expressed in
cancer tissues in comparison with benign tissue and it has
been known to be a DNA oxidative damage marker in cancer
cells (36). H2O2 treatment of cells resulted in an increase of
8-OHdG level (36, 37). 8-OHdG level was increased in PC-
3/SOD3 cells, suggesting that accumulation of H2O2 caused
by SOD3 overexpression or SOD3 treatment might induce
DNA oxidative damage and cause cell death. Taken together,
SOD3 overexpression or recombinant SOD3 treatment might
contribute to inhibition of cell proliferation, migration, and
invasion. 
In conclusion, we revealed the function of SOD3 as a
tumor suppressor in PC-3 cells. For the development of a
prospective antioxidant therapy, we further need to elucidate
functional influences and mechanical pathways of
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